PPT-Pharmacologic Approaches to Treating CKD in Type 2 DM (1)

Metformin must be considered the cornerstone of treatment when not contraindicated eGFR lt30 In patients not at goal on metformin monotherapy adding an SGLT 2 inhibitor like empagliflozin is warranted when not contraindicated eGFR lt45 CVD benefit Class effect. brPage 1br Treating Stomach Cancer A Quick Guide brPage 2br Treating Stomach Cancer A Quick Guide brPage 3br Treating Stomach Cancer A Quick Guide brPage 4br Treating Stomach C Program Goals. Hepcidin in Chronic Kidney Disease. Treatment of Iron Deficiency Anemia. Assessment of IV Iron in Patients With Non-Dialysis-Dependent CKD. DOPPS Study. Ferric Pyrophosphate. Phosphate Binders. 1 Table 1.1 Distribution of NHANES participants with diabetes, self-reported cardiovascular disease, & single sample markers of CKD, 2007-2012. Data Source: National Health and Nutrition Examination Survey (NHANES), 1988–1994, 1999-2004 & 2005–2012 participants age 20 & older. Note: Cardiovascular disease designation is based on self-report of any CVD condition (see CKD Analytical Methods chapter for detail); CKD is defined as eGFR <60 or ACR ≥30. Abbreviations: ACR, urine albumin/creatinine ratio; CKD, chronic kidney disease; SR CVD, self-reported cardiovascular disease; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; . not applicable.. Chapter 1: CKD in the General Population 2017 Annual Data Report Volume 1: Chronic Kidney Disease 2 Table A Kidney Disease Outcomes and Quality Improvement (KDOQI) CKD Staging Guidelines CKD Stage Description Case 201-cv-00779-WBS -CKD Document 142 Filed 04/29/05 Page 2 of 2123456789-1- RD 1234567892 R Lowell Dilworth-Chemical Pathologist. CKD. CKD and Bone disease. Mineral . metabolism controlled by kidneys. , intestine, parathyroid glands and . bone. The . kidney plays a critical role in mineral homeostasis regulation and, therefore, renal disease exerts widespread effects on the skeleton and soft . Definition of CKD. Staging of CKD. Etiology of CKD. How to measure Kidney function . Incidence of ESRD. (per million population, 1990, by HSA, unadjusted). USRDS, 2000. Incidence of ESRD. (per million population, 2000, by HSA, unadjusted) . KDIGO 2017 Clinical Practice Guideline Update. Speaker’s Guide. Summary of KDIGO CKD-MBD Guideline Recommendations. This Speaker’s Guide combines the new recommendation statements . (noted in green) . . Structural . or functional abnormalities of the kidneys for . >. 3 months. . from early to late-stage disease, . Chronic Kidney Disease. as . manifested by either:. 1. Kidney . damage, with or without decreased GFR, as . Hyperkalemia, Metabolic Acidosis, Malnutrition, Depression & Acute Kidney Injury. Andrew . Narva. , MD, FASN & . Amy Barton . Pai. , PharmD, MHI, FASN, FCCP, FNKF. Andrew . Narva. , MD, FASN. In CKD and HD patients dysfunction of . immu. ne . sy. stem . a. lterations. . belonge. to . . involv. ing. . i. nnate. and . a. daptive. . i. mmunity. in T and B lymphocytes (. Reduced . T regulatory cells and memory cells and increased innate cells). . Type II and Pre Diabetes Eat Right 4 Your Type | Featuring brandnew targeted food and supplement lists specific to diabetes that readers wont find anywhere elseAmericas fastestgrowing health problem just got dealt a major blow Dr Peter J DAdamo the creator of the Blood Type Diet which has forever c .. สุดารัตน์ . ศุภ. กิจเจริญ. หน่วยงานวิสัญญี โรงพยาบาลกำแพงเพชร. Etiology of CKD. In UK , most common causes are;. Konstantia. Ass. Prof. of Nephrology D.U.TH.. Reduced quality of life . van Haalen et al. BMC Nephrology 2020. Worse renal survival. Lamerato et al. BMC Nephrology 2022. Increase in morbidity and mortality.